Key events in cancer: Dysregulation of SREBPs
Yunkuo Li(Sichuan University), Honglan Zhou(Jilin University), Shouwang Wu(Jilin University), Bin Liu(Jilin University), Xiaodong Zhao(Jilin University), Yishu Wang(First Bethune Hospital of Jilin University), Faping Li(Jilin University), Difei Zhang(Jilin University), Hao Shiming(Jilin University), Yu-Xiong Wang(Jilin University)
Cited by 48
Related Papers
Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression
|Clinical Nutrition|2023|106
The role of transketolase in human cancer progression and therapy
|Biomedicine & Pharmacotherapy|2022|65
Role of mitochondria in pathogenesis and therapy of renal fibrosis
|Metabolism|2024|57
LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma
|Cancer Letters|2024|50
Regulatory mechanisms of the cAMP-responsive element binding protein 3 (CREB3) family in cancers
|Biomedicine & Pharmacotherapy|2023|38